Stanford team uses Virtual Biotech AI to find lung cancer drug signal
A Stanford University group described an artificial intelligence system called Virtual Biotech in the journal Science that identified a potential lung cancer treatment.
Autonomous agent teams work continuously
The system consists of up to 37,000 agents that interact with large language models or each other. These agents perform multistep tasks without needing meals, sleep, or distraction from humans.
AI uncovered a molecular signal
The artificial intelligence system found a specific molecular signal capable of predicting success in clinical trials. With human oversight, the team used this finding to identify a promising therapy for lung cancer patients.
Experts question real-world validation
Some scientists state that the Virtual Biotech has not yet been tested in actual drug discovery environments. Additionally, the predictions made by the system have not undergone experimental verification or clinical trial evaluation.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.